Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
Schoot, Lara S., Atalay, Selma, Otero, Marisol E., Kievit, Wietske, Reek, Juul M.P.A., Jong, Elke M.G.J.
Published in British journal of dermatology (1951) (01.12.2022)
Published in British journal of dermatology (1951) (01.12.2022)
Get full text
Journal Article
Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice
Atalay, Selma, van der Schoot, Lara S, Vandermaesen, Laura, van Vugt, Lieke J, Eilander, Mascha, van den Reek, Juul M P A, de Jong, Elke M G J
Published in Acta dermato-venereologica (25.05.2021)
Published in Acta dermato-venereologica (25.05.2021)
Get full text
Journal Article
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
van der Schoot, Lara S, van den Reek, Juul M. P. A, Grine, Lynda, Schots, Lisa, Kievit, Wietske, Lambert, Jo L. W, de Jong, Elke M. G. J
Published in Current controlled trials in cardiovascular medicine (16.10.2021)
Published in Current controlled trials in cardiovascular medicine (16.10.2021)
Get full text
Journal Article
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review
van Winden, Marieke E C, van der Schoot, Lara S, van de L'Isle Arias, Mariluz, van Vugt, Lieke J, van den Reek, Juul M P A, van de Kerkhof, Peter C M, de Jong, Elke M G J, Lubeek, Satish F K
Published in JAMA dermatology (Chicago, Ill.) (01.11.2020)
Published in JAMA dermatology (Chicago, Ill.) (01.11.2020)
Get more information
Journal Article